D. E. Shaw & Co., Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
4,410
Total Value
56236260077
Accession Number
0001104659-25-049422
Form Type
13F-HR
Manager Name
D. E. Shaw & Co., Inc.
Data Enrichment
86% identified
3,801 identified609 unidentified

Holdings

4,410 positions
Manager:
Search and click to pin securities to the top
Page 150 of 157
76155X118
Shares:
1454895(+0.0%)
Value:
$55.3M(-76.5%)
Foghorn Therapeutics Inc.
Shares:
14875(-85.2%)
Value:
$54.3M(-88.5%)
ARKO Corp.
Shares:
13534(-49.0%)
Value:
$53.5M(-69.4%)
CATO CORP
Shares:
15581(-8.7%)
Value:
$51.9M(-22.1%)
Bitcoin Depot Inc.
Shares:
675425(+0.0%)
Value:
$50.7M(+17.2%)
Inozyme Pharma, Inc.
Shares:
53381(+199.7%)
Value:
$48.6M(-1.6%)
G4411J114
Shares:
200000(+0.0%)
Value:
$48.4M(-81.4%)
BEYOND MEAT, INC.
Shares:
15807(-73.7%)
Value:
$48.2M(-78.6%)
G6001J131
Shares:
200000
Value:
$48.0M
ALX ONCOLOGY HOLDINGS INC
Shares:
75900(-70.3%)
Value:
$47.3M(-88.9%)
G7633M112
Shares:
150000
Value:
$46.9M
ChargePoint Holdings, Inc.
Shares:
73074(-95.1%)
Value:
$44.2M(-97.2%)
Erasca, Inc.
Shares:
31429(-91.5%)
Value:
$43.1M(-95.3%)
731105102
Shares:
230468(+0.0%)
Value:
$42.3M(+33.0%)
36170N115
Shares:
575000(+155.6%)
Value:
$41.6M(+37.1%)
W&T OFFSHORE INC
Shares:
26800(+0.0%)
Value:
$41.5M(-6.6%)
Lyell Immunopharma, Inc.
Shares:
77178(-92.0%)
Value:
$41.5M(-93.3%)
74841A113
Shares:
23000(+0.0%)
Value:
$37.0M(+15.0%)
43538H111
Shares:
732036(+0.0%)
Value:
$36.6M(-9.1%)
WW INTERNATIONAL, INC.
Shares:
70000(+396.4%)
Value:
$36.6M(+104.3%)